Sensus Healthcare director William McCall passes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Sensus Healthcare Announces the Passing of Director Bill McCall
October 31, 2025 8:00 AM EDTBOCA RATON, Fla.--(BUSINESS WIRE)-- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the passing of longtime friend of the Company and current Director William Bill McCall.
Bills involvement with Sensus dates to 2009, when he played a key role in transforming the company from concept to reality. He led the Companys initial capital raise in 2010 while serving as CEO of Anderson Strudwick, a boutique investment banking firm. He joined the Sensus Healthcare Board of... More
